Add BrightSurf on Google Email

University of California - Los Angeles Health Sciences


UCLA researchers uncover mechanism by which melanoma drug accelerates secondary skin cancers

Researchers found that blocking the mutated BRAF protein in melanoma cells sets off a cellular cascade in other skin cells with pre-disposing mutations, leading to accelerated development of skin squamous cell carcinomas. The study provides molecular insight into this side effect and suggests strategies to prevent secondary tumors.

SourceUniversity of California - Los Angeles Health Sciences·JournalNew England Journal of Medicine·DateJan 18, 2012

Home monitoring may help manage and reduce costs for heart failure

A new study suggests that home monitoring strategies, including self-care, phone calls from nurses, and telemedicine, can effectively track heart failure disease-management and early identification. The authors recommend a multi-pronged approach, combining monitoring with patient follow-up and feedback to improve outcomes.

SourceUniversity of California - Los Angeles Health Sciences·JournalJournal of the American College of Cardiology·DateJan 3, 2012

Bush embryonic stem cell lines different from newly derived cell lines

Researchers found that newly derived human embryonic stem cell lines have a better molecular signature than established lines, indicating higher quality and potentially better performance in disease modeling. The study suggests that maintaining the original state of X chromosome inactivation could be crucial for achieving optimal results.

SourceUniversity of California - Los Angeles Health Sciences·JournalHuman Molecular Genetics·DateNov 30, 2011

Combo hormone therapy has increased breast cancer risk over estrogen alone

A recent study found that women taking combination estrogen and progestin menopausal hormone therapy are at a greater risk of developing breast cancer if they experience new onset breast tenderness. In contrast, women on estrogen alone without breast tenderness did not have an increased risk of breast cancer.

SourceUniversity of California - Los Angeles Health Sciences·JournalBreast Cancer Research and Treatment·DateNov 17, 2011

UCLA stem cell researchers uncover mechanism that regulates human pluripotent stem cell metabolism

Researchers found that pluripotent stem cells respire at the same level as differentiated body cells but produce very little energy. UCP2 protein blocks respiration substrates from entering mitochondria, allowing glycolysis to dominate. The study suggests that changes in metabolism drive cell differentiation.

Breast tenderness in women getting combo hormone therapy associated with increase in breast density

Post-menopausal women experiencing new onset breast tenderness after starting combination hormone therapy may have an increased risk of breast cancer compared to those without breast tenderness. Higher breast density is associated with a higher risk of breast cancer, with extremely dense breasts posing a four to six times higher risk.

SourceUniversity of California - Los Angeles Health Sciences·JournalBreast Cancer Research and Treatment·DateOct 13, 2011

Survival increased in early stage breast cancer after treatment with herceptin and chemo

A study by UCLA's Jonsson Comprehensive Cancer Center found that a combination of chemotherapy and Herceptin significantly increases survival in patients with HER-2 positive breast cancer. The regimen without Adriamycin was comparable to the standard therapy, reducing heart toxicity and acute side effects.

SourceUniversity of California - Los Angeles Health Sciences·JournalNew England Journal of Medicine·DateOct 5, 2011

UCLA researchers develop system that finds prostate cancer spread earlier than conventional imaging

Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a gene-based imaging system that can detect castration-resistant prostate cancer earlier than conventional methods. The system uses specific genes and reporter genes to accurately identify the spread of the disease, giving oncologists more time to treat it and pot...

Estrogen treatment may help reverse severe pulmonary hypertension

Researchers at UCLA found that estrogen treatment can reverse the progression of pulmonary hypertension to heart failure and restore lung and ventricle structure and function. The study suggests that even short-term estrogen therapy may suffice to reverse the disease, offering new potential therapeutic applications for human patients.

SourceUniversity of California - Los Angeles Health Sciences·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateSep 15, 2011

Primary component in turmeric kicks off cancer-killing mechanisms in human saliva

A pilot study using human saliva found that curcumin inhibited a critical cell signaling pathway and reduced pro-inflammatory cytokines in patients with head and neck cancers. The study suggests curcumin could be combined with other treatments to treat head and neck cancer, and may be given to high-risk patients as an adjuvant treatment.

SourceUniversity of California - Los Angeles Health Sciences·JournalClinical Cancer Research·DateSep 12, 2011

New limits on physician training hours could prove costly for US teaching hospitals

The new duty-hour limits will require US teaching hospitals to spend up to $1.3 billion a year on implementing the changes, which aim to reduce medical errors caused by fatigue. The reforms also introduce changes in the training environment, including standardized hand-overs and education on fatigue and patient safety.

SourceUniversity of California - Los Angeles Health Sciences·JournalJournal of General Internal Medicine·DateSep 8, 2011

Metabolic state of brain cancer stem cells significantly different than the cancer cells they create

Researchers at UCLA found that brain cancer stem cells can change their metabolic state from glycolysis to oxidative phosphorylation, allowing them to evade treatment. This unique ability makes glioma stem cells resistant to conventional treatments, highlighting the need for new therapies targeting these cells specifically.

SourceUniversity of California - Los Angeles Health Sciences·JournalProceedings of the National Academy of Sciences·DateSep 6, 2011

UCLA study shows loss of key estrogen regulator may lead to metabolic syndrome and atherosclerosis

A UCLA study reveals that the loss of a critical protein regulating estrogen and immune activity can lead to metabolic syndrome, characterized by Type 2 diabetes, atherosclerosis, and cancer. The research found that this protein's absence promotes increased fat accumulation, inflammation, and glucose intolerance in female mice.

SourceUniversity of California - Los Angeles Health Sciences·JournalProceedings of the National Academy of Sciences·DateSep 6, 2011

UCLA memory fitness program improves memory abilities of oldest adults

A new UCLA study found that a six-week memory fitness program improved verbal memory and reduced age-related memory decline in seniors over 80. The program included education on lifestyle factors impacting memory ability and overall brain health, resulting in enhanced self-perceived memory and cognitive function.

SourceUniversity of California - Los Angeles Health Sciences·JournalAmerican Journal of Geriatric Psychiatry·DateAug 29, 2011

Results of medication studies in top medical journals may be misleading to readers

A study analyzing medication trials published in high-impact general medicine journals found that surrogate outcomes, composite outcomes, and disease-specific mortality are used, which can be misleading. These outcome measures may not accurately reflect a medication's impact on important clinical outcomes like heart attacks or strokes.

SourceUniversity of California - Los Angeles Health Sciences·JournalJournal of General Internal Medicine·DateAug 25, 2011

Extreme morning sickness could lead to lifelong emotional, behavioral disorders in kids

Research finds children of mothers with extreme morning sickness may suffer from anxiety, bipolar disorder, and depression as adults. A UCLA-USC study suggests prolonged malnutrition and stress during fetal brain development could contribute to these lifelong neurobehavioral disorders.

SourceUniversity of California - Los Angeles Health Sciences·JournalJournal of Developmental & Behavioral Pediatrics·DateAug 23, 2011

Study identifies new way to treat common hospital-acquired infection

Researchers identify a molecular process by which human cells can neutralize toxins released by Clostridium difficile, offering a promising new treatment for intestinal disease. The discovery could also be applied to other bacterial diseases and has the potential to revolutionize the treatment of hospital-acquired infections.

Cells derived from pluripotent stem cells are developmentally immature

Researchers found that human embryonic stem cell-derived cells bear striking differences from human tissue cells in gene expression, functionality, and appearance. The cells' developmental maturity is also a concern, particularly for transplantation and disease modeling, as they may not mature to the same levels as adult cells.

UCLA stem cell scientists uncover for the first time why the human heart can't regenerate itself

Researchers at UCLA have found that adult human cardiac myocytes lose their ability to proliferate due to their primitive state being incompatible with proper heart function. This knowledge could lead to reprogramming a patient's own cardiac myocytes to replace damaged heart muscle, potentially revolutionizing treatments for heart cond...

SourceUniversity of California - Los Angeles Health Sciences·JournalJournal of Cell Biology·DateAug 8, 2011

Nearly all patients with high-grade bladder cancer do not receive guideline-recommended care

A recent study by UCLA found that nearly all patients with high-grade, non-invasive bladder cancer are not receiving comprehensive care recommended by the American Urology Association and National Comprehensive Cancer Network. This is critical as it can significantly minimize the likelihood of patient death from their cancer.